Literature DB >> 18500061

Evaluation and treatment of osteochondritis dissecans lesions of the knee.

Alvin J Detterline1, Jordan L Goldstein, John-Paul H Rue, Bernard R Bach.   

Abstract

Osteochondritis dissecans (OCD) is a condition affecting the subchondral bone of joints with secondary effects on articular cartilage that results in pain, effusions, loose-body formation, and mechanical symptoms. Left untreated, OCD can lead to the development of degenerative arthritis secondary to joint incongruity and abnormal wear patterns. This article discusses the etiology of knee OCD lesions, clinical presentation, proper evaluation, and treatment options. Treatment of OCD may include nonoperative measures or operative procedures ranging from drilling or fixation of fragments to complex reconstruction procedures such as autologous chondrocyte implantation, osteochondral autograft, and fresh osteochondral allograft. Physicians must consider many factors, including the patient's age and skeletal maturity, as well as size, location, and stability of OCD lesions to determine the proper course of treatment.

Entities:  

Mesh:

Year:  2008        PMID: 18500061     DOI: 10.1055/s-0030-1247804

Source DB:  PubMed          Journal:  J Knee Surg        ISSN: 1538-8506            Impact factor:   2.757


  25 in total

Review 1.  The clinical utility and diagnostic performance of MRI for identification and classification of knee osteochondritis dissecans.

Authors:  Carmen E Quatman; Catherine C Quatman-Yates; Laura C Schmitt; Mark V Paterno
Journal:  J Bone Joint Surg Am       Date:  2012-06-06       Impact factor: 5.284

Review 2.  Treatment of unstable knee osteochondritis dissecans in the young adult: results and limitations of surgical strategies-The advantages of allografts to address an osteochondral challenge.

Authors:  Giuseppe Filardo; Luca Andriolo; Francesc Soler; Massimo Berruto; Paolo Ferrua; Peter Verdonk; Frederic Rongieras; Dennis C Crawford
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2018-12-06       Impact factor: 4.342

3.  Poor osteochondral repair by a biomimetic collagen scaffold: 1- to 3-year clinical and radiological follow-up.

Authors:  Bjørn Borsøe Christensen; Casper Bindzus Foldager; Jonas Jensen; Niels Christian Jensen; Martin Lind
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2015-02-18       Impact factor: 4.342

4.  Osteochondritis dissecans development after bone contusion of the knee in the skeletally immature: a case series.

Authors:  Kevin G Shea; John C Jacobs; Nathan L Grimm; Ronald P Pfeiffer
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2012-04-06       Impact factor: 4.342

5.  Surgical management of osteochondritis dissecans of the knee.

Authors:  Brandon J Erickson; Peter N Chalmers; Adam B Yanke; Brian J Cole
Journal:  Curr Rev Musculoskelet Med       Date:  2013-06

6.  Surgical treatment for osteochondritis dessicans of the knee.

Authors:  Zachary Winthrop; Gregory Pinkowsky; William Hennrikus
Journal:  Curr Rev Musculoskelet Med       Date:  2015-12

7.  Arthroscopic preparation and internal fixation of an unstable osteochondritis dissecans lesion of the knee.

Authors:  Christopher L Camp; Aaron J Krych; Michael J Stuart
Journal:  Arthrosc Tech       Date:  2013-11-08

8.  Treatment of a lateral tibial plateau osteochondritis dissecans lesion with subchondral injection of calcium phosphate.

Authors:  Geoffrey D Abrams; Eduard Alentorn-Geli; Joshua D Harris; Brian J Cole
Journal:  Arthrosc Tech       Date:  2013-07-19

9.  Matrix-assisted chondrocyte transplantation with bone grafting for knee osteochondritis dissecans: stable results at 12 years.

Authors:  Luca Andriolo; Alessandro Di Martino; Sante Alessandro Altamura; Angelo Boffa; Alberto Poggi; Maurizio Busacca; Stefano Zaffagnini; Giuseppe Filardo
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2020-08-18       Impact factor: 4.342

10.  Chondrogenesis of cocultures of mesenchymal stem cells and articular chondrocytes in poly(l-lysine)-loaded hydrogels.

Authors:  Yu Seon Kim; Athena J Chien; Jason L Guo; Brandon T Smith; Emma Watson; Hannah A Pearce; Gerry L Koons; Adam M Navara; Johnny Lam; David W Scott; K Jane Grande-Allen; Antonios G Mikos
Journal:  J Control Release       Date:  2020-09-30       Impact factor: 9.776

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.